InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Monday, 10/13/2014 10:25:58 AM

Monday, October 13, 2014 10:25:58 AM

Post# of 80868
Musclepharm needs to get rid of these three ghosts

1) Lack of profitability

2) Excessive dilution of stock price

3) Sec investigation


Whenever these 3 are gone...which could be next month....then the sky is the limit...until then $18 is most likely the limit.

I think the first ghost is gone already as Musclepharm most likely will be posting profits going forward. A guidance that doesn't understate reality would indicate less dilution. If management wants to dilute, it wants to announce a huge jump in earnings AFTER announcing a highly dilutive employees incentives plan.

Working hard on getting concluded the SEC investigation would in itself prove that management wants to act like a Nasdaq listed company, and not like the Fed or bank of Japan, Argentina...printing money.